{{Drugbox
| Verifiedfields = changed
| verifiedrevid = 400279517
| image =  
<!-- Monoclonal antibody data -->
| type = mab
| mab_type =
| source = o
| target = [[MUC1]]
<!-- Clinical data -->
| tradename = Theragyn
| pregnancy_AU =  
| pregnancy_US =  
| pregnancy_category =  
| legal_AU =  
| legal_CA =  
| legal_UK =  
| legal_US =  
| legal_status =  
| routes_of_administration = [[Intraperitoneal]]
<!-- Pharmacokinetic data -->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =  
<!-- Identifiers -->
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}}
| ChemSpiderID = none
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number =  
| ATC_prefix = none
| ATC_suffix =  
| PubChem =  
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
<!-- Chemical data -->
| chemical_formula =  
| molecular_weight =  
}}

'''Pemtumomab''' (trade name '''Theragyn''') is a [[mouse]] [[monoclonal antibody]] used to treat cancer. The substance has affinity to various types of cancer, like [[ovarian cancer]] and [[peritoneal cancer]], via the [[polymorphic epithelial mucin]] (PEM or MUC-1) and delivers the [[radioisotope]] [[Yttrium-90]] into the tumour.<ref>{{cite journal|pmid=18661524|year=2008|last1=Oei|first1=AL|last2=Moreno|last3=Verheijen|last4=Sweep|last5=Thomas|last6=Massuger|last7=Von Mensdorff-Pouilly|title=Induction of IgG antibodies to MUC1 and survival in patients with epithelial ovarian cancer|volume=123|issue=8|pages=1848â€“53|doi=10.1002/ijc.23725|journal=International Journal of Cancer. Journal International Du Cancer|first2=M|first3=RH|first4=FC|first5=CM|first6=LF|first7=S}}</ref> {{As of|2009}}, it is undergoing Phase III [[clinical trials]].<ref>[http://www.clinicaltrials.gov/ct2/show/NCT00004115 ClinicalTrials.gov]</ref>

It has been granted [[orphan drug]] status in Europe.<ref>[http://www.highbeam.com/doc/1G1-75186555.html Antisoma's Lead Product, Pemtumomab Granted European Orphan Drug Status]</ref>

==References==
{{reflist}}

{{Monoclonals for tumors}}

[[Category:Monoclonal antibodies for tumors]]
[[Category:Orphan drugs]]
[[Category:Experimental drugs]]


{{monoclonal-antibody-stub}}
{{antineoplastic-drug-stub}}